Filter your results
- 2
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 1
- 1
- 1
|
|
sorted by
|
|
Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington’s DiseaseFrontiers in Neurology, 2017, 8, pp.519. ⟨10.3389/fneur.2017.00519⟩
Journal articles
hal-01622576v1
|
||
|
Prediction of biomarkers' trajectory in Huntington's disease: application to precise clinical trial designCompAge 2020 - Computational approaches for ageing and age-related diseases, Sep 2020, Paris, France
Conference papers
hal-03137994v1
|
||
|
Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s DiseaseFrontiers in Neurology, 2021, 12, pp.616272. ⟨10.3389/fneur.2021.616272⟩
Journal articles
hal-03217707v1
|